Nature Search

Evidence from angle-resolved resonant photoemission for oxygen-2p nature of the Fermi-liquid states in Bi₂CaSr₂Cu₂O₈

T. Takahashi
H. Matsuyama
H. Inokuchi
Research01 Aug 1988
Nature

Volume: 334, P: 691-692
Evidence for non-metallic nature of the BiO plane in Bi₂CaSr₂Cu₂O₈ from scanning tunnelling spectroscopy

M. Tanaka
T. Takahashi
K. Kajimura
Research29 Jun 1989
Nature

Volume: 339, P: 691-693
Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation

Stem cell factor (SCF) is a cytokine with great potential for treating ischemia, stroke and heart attack, but therapies using SCF have been limited by acute allergic responses. The work describes a new therapeutic using transmembrane SCF delivered in lipid nanocarriers that is effective in treating ischemia without off-target effects.

Eri Takematsu
Miles Massidda
Aaron B. Baker
ResearchOpen Access06 May 2022
Nature Communications

Volume: 13, P: 1-13
Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness

Hand grip strength as a proxy of muscular fitness is a clinical predictor of mortality and morbidity. In a large-scale GWA study, the authors find 16 robustly associated genetic loci that highlight roles in muscle fibre structure and function, neuronal maintenance and nervous system signal transduction.

Sara M. Willems
Daniel J. Wright
Robert A. Scott
ResearchOpen Access12 Jul 2017
Nature Communications

Volume: 8, P: 1-12
Mechanobiological conditioning of mesenchymal stem cells for enhanced vascular regeneration

Human mesenchymal stem cells can be mechanically and pharmacologically conditioned to enhance vascular regeneration in vivo, as shown in mice with hindlimb ischaemia.

Jason Lee
Kayla Henderson
Aaron B. Baker
Research22 Jan 2021
Nature Biomedical Engineering

Volume: 5, P: 89-102
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer

Tommaso Cai
Irene Tamanini
Cosimo De Nunzio
Research30 Mar 2024
Prostate Cancer and Prostatic Diseases

Volume: 27, P: 300-304
Transmembrane stem factor nanodiscs enhanced revascularization in a hind limb ischemia model in diabetic, hyperlipidemic rabbits

Eri Takematsu
Miles Massidda
Aaron B. Baker
ResearchOpen Access29 Jan 2024
Scientific Reports

Volume: 14, P: 1-9
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

J Y Douillard
D Lerouge
A Rivière
ResearchOpen Access01 May 2001
British Journal of Cancer

Volume: 84, P: 1179-1184
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

F Di Costanzo
P Carlini
S Gasperoni
ResearchOpen Access28 Jun 2005
British Journal of Cancer

Volume: 93, P: 185-189
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Annamaria Ruzzo
Francesco Graziano
Mauro Magnani
ResearchOpen Access08 Aug 2019
Scientific Reports

Volume: 9, P: 1-9
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo
Francesco Graziano
Mauro Magnani
ResearchOpen Access05 Nov 2014
Scientific Reports

Volume: 4, P: 1-7
Thermostatic properties of nitrate molten salts and their solar and eutectic mixtures

B. D’Aguanno
M. Karthik
A. Floris
ResearchOpen Access11 Jul 2018
Scientific Reports

Volume: 8, P: 1-15
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

A Ruzzo
F Graziano
M Magnani
ResearchOpen Access24 Aug 2017
British Journal of Cancer

Volume: 117, P: 1269-1277
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Annamaria Ruzzo
Francesco Graziano
Mauro Magnani
Amendments and CorrectionsOpen Access31 Jan 2020
Scientific Reports

Volume: 10, P: 1
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

P Comella
G Frasci
R Cioffi
ResearchOpen Access13 Jul 2004
British Journal of Cancer

Volume: 91, P: 489-497
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study

S De Placido
M Lopez
A R Bianco
ResearchOpen Access11 Oct 2005
British Journal of Cancer

Volume: 93, P: 896-904

Search

Filter By:

Search

Quick links